The stock of Bausch Health Companies Inc. (NYSE:BHC) increased by $0.22 on Tuesday to finish at $8.48, up 2.66 percent. The last five days have seen an average of 2,422,720 shares of common stock traded. 17 times new highs were reached in the current year, with a gain of $2.20. The average number of shares traded over the last 20 days was 2,913,060, while the average volume over the last 50 days totaled 2,428,172.
BHC stock dropped -12.67% since last month. On 08/25/23, the company’s shares reached a one-month low of $7.93. The stock touched a high of $10.23 on 02/23/23, after rallying from a low of $4.99 in 52 weeks. The price of BHC stock has risen by 35.03% or $2.20 this year, reaching a new high 17 times. Still, the stock price is down -17.11% from the 52-week high.
Insider Transactions
BHC stock investors should be aware that Bausch Health Companies Inc. (BHC) stock had its last reported insider trading activity 183 days ago on Feb 28. On Feb 28, EVP, General Counsel Carson Seana sold 292 shares at $9.32 each. This transaction resulted in the insider making $2,721.
Financial Health
For the three months ended June 29, Bausch Health Companies Inc.’s quick ratio was 0.80, while its current ratio was 1.10, indicating its inability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 70.50% percent. Bausch Health Companies Inc.’s EBITDA margin for the year ended June 29 was 34.28%, whereas its operating margin stood at 16.30% for the same period. Based on annual data, it had gross profit of $5.76 billion and revenue of $8.12 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. BHC’s return on assets (ROA) during the last 12 months has been -0.70%. There was a 6.20% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 27.80%.
Earnings Surprise
According to Bausch Health Companies Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $2.17 billion, while revenues rose by 9.23% to $1.94 billion. It was predicted that Bausch Health Companies Inc.’s quarterly earnings would be $0.82, but it ended up being $0.78, beating the consensus by 5.10%. EBITDA was $739.0 million for the quarter. At the end of Bausch Health Companies Inc.’s most recent quarter ended June 29, its liabilities totaled 25.23 billion, while its total debt was $20.55 billion. Equity owned by shareholders amounts to $364.33 million.
Technical Picture
Here’s a quick look at Bausch Health Companies Inc.’s (BHC) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 51.57%, suggesting the stock is Neutral, with a 24.41% historical volatility rate.
The stochastic %K and %D were 44.89% and 26.29% respectively, while the average true range (ATR) was 0.32. Based on the 14-day stochastic reading of 70.97%, the RSI (14) reading is 48.93%. On the 9-day MACD Oscillator, the stock is at 0.04, and the 14-day reading is at 0.01.
Analyst Ratings
Bausch Health Companies Inc. (NYSE: BHC) was downgraded by TD Cowen to a a Market perform rating in its latest research report. The stock was previously rated as a an Outperform. Analysts have assigned Bausch Health Companies Inc. (BHC) an Hold rating. BHC is a stock that is recommended for selling by 0 brokerage firms, while 5 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is BHC’s price target for the next 12 months?
The current consensus forecast for the stock is between $6.00 and $12.00, with a median target price of $8.50. In analyzing these forecasts, the average price target given by analysts for Bausch Health Companies Inc. (BHC) is $8.50.
